Dong H, Wang N, Zhao L, Lu F, « Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis », Evid Based Complement Alternat Med, vol. 2012, , p. 591654 (PMID23118793, PMCID3478874, DOI10.1155/2012/591654)
Dong H, Zhao Y, Zhao L, Lu F, « The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials », Planta Med., vol. 79, no 6, , p. 437–46 (PMID23512497, DOI10.1055/s-0032-1328321)
Zhao H, Halicka HD, Li J, Darzynkiewicz Z. Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging (Albany) 2013; 6: 623–636. PMID23974852, DOI10.18632/aging.100593
Darzynkiewicz Z, Zhao H, Halicka HD, Li J, Lee Y-S, Hsieh T-C, Wu J. In search of anti-aging modalities: evaluation of mTOR- and ROS/DNA damage- signaling by cytometry. Cytometry A 2014;85A:386-99. PMID24677687, DOI10.1002/cyto.a.22452
Liu CS, Zheng YR, Zhang YF, Long XY, « Research progress on berberine with a special focus on its oral bioavailability », Fitoterapia, vol. 109, , p. 274–82 (PMID26851175, DOI10.1016/j.fitote.2016.02.001)
Shiyue Liu, Yi Zhang, Ping Zeng et Heli Wang, « Isolation and Characterization of a Bacterial Strain Capable of Efficient Berberine Degradation », International Journal of Environmental Research and Public Health, vol. 16, no 4, , p. 646 (ISSN1660-4601, DOI10.3390/ijerph16040646, lire en ligne, consulté le )
Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YO, « Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus », Journal of Medicinal Food, vol. 8, no 4, , p. 454–61 (PMID16379555, DOI10.1089/jmf.2005.8.454)
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K, « Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor », Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no 4, , p. 1433–7 (PMID10677479, PMCID26451, DOI10.1073/pnas.030540597, Bibcode2000PNAS...97.1433S)
Zhang S, Zhang B, Xing K, Zhang X, Tian X, Dai W, « Inhibitory effects of golden thread (Coptis chinensis) and berberine on Microcystis aeruginosa », Water Science & Technology, vol. 61, no 3, , p. 763–9 (PMID20150713, DOI10.2166/wst.2010.857)
Rui Zhang, Jie Yang, Juan Wu et Lingling Xiao, « Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration », European Journal of Pharmacology, vol. 851, , p. 144–150 (ISSN0014-2999, DOI10.1016/j.ejphar.2019.02.026, lire en ligne, consulté le )
(en) Chen Xiao, Yan Liu, Qiang Wei et Quan Ji, « Inhibitory Effects of Berberine Hydrochloride on Trichophyton mentagrophytes and the Underlying Mechanisms », Molecules, vol. 24, no 4, , p. 742 (ISSN1420-3049, DOI10.3390/molecules24040742, lire en ligne, consulté le )
(en) Anna Luganini, Beatrice Mercorelli, Lorenzo Messa et Giorgio Palù, « The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity. », Antiviral Research, vol. 164, , p. 52–60 (DOI10.1016/j.antiviral.2019.02.006, lire en ligne, consulté le )
(en) Ting-Chun Hung, Alagie Jassey, Ching-Hsuan Liu et Chien-Ju Lin, « Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein », Phytomedicine, vol. 53, , p. 62–69 (DOI10.1016/j.phymed.2018.09.025, lire en ligne, consulté le )
(en) Mariana Batista, Ana Braga, Guilherme Campos et Marcos Souza, « Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus », Viruses, vol. 11, no 1, , p. 49 (ISSN1999-4915, DOI10.3390/v11010049, lire en ligne, consulté le )
(en) Matteo Pirro, Daniela Francisci, Vanessa Bianconi et Elisabetta Schiaroli, « NUtraceutical TReatment for hypercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial », Atherosclerosis, vol. 280, , p. 51–57 (DOI10.1016/j.atherosclerosis.2018.11.026, lire en ligne, consulté le )
Shi-Fen Dong, Ying Hong, Ming Liu et Ying-Zhi Hao, « Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats », European Journal of Pharmacology, vol. 660, nos 2-3, , p. 368–374 (ISSN0014-2999, DOI10.1016/j.ejphar.2011.03.024, lire en ligne, consulté le )
Younggeon Jin et Anthony T. Blikslager, « Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury », American Journal of Physiology-Cell Physiology, vol. 311, no 6, , C996–C1004 (ISSN0363-6143 et 1522-1563, DOI10.1152/ajpcell.00113.2016, lire en ligne, consulté le )
Zhouqing Huang, Zhihua Han, Bozhi Ye et Zhenyu Dai, « Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes », European Journal of Pharmacology, vol. 762, , p. 1–10 (ISSN0014-2999, DOI10.1016/j.ejphar.2015.05.028, lire en ligne, consulté le )
Rongxin Zhang, Yuan Yuan Zhang, Xiao R. Huang et Yin Wu, « C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II–Induced Hypertensive Cardiac Disease », Hypertension, vol. 55, no 4, , p. 953–960 (ISSN0194-911X et 1524-4563, DOI10.1161/hypertensionaha.109.140608, lire en ligne, consulté le )
Yuxuan Qiu, Yuanyuan Xie, Kuijing Wang et Gengfeng Liu, « Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways », Experimental and Therapeutic Medicine, vol. 17, no 1, , p. 230–236 (ISSN1792-0981, PMCIDPMC6307361, DOI10.3892/etm.2018.6949, lire en ligne, consulté le )
Hao Chen, Ruo-Qing Zhang, Xiao-Gang Wei et Xiao-Min Ren, « Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse », Asian Pacific Journal of Tropical Medicine, vol. 9, no 5, , p. 503–507 (ISSN1995-7645, DOI10.1016/j.apjtm.2016.03.021, lire en ligne, consulté le )
Yao-Jun Zhang, Shao-Hua Yang, Ming-Hui Li et Javaid Iqbal, « Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: Role of autophagy », Clinical and Experimental Pharmacology and Physiology, vol. 41, no 12, , p. 995–1002 (ISSN0305-1870, DOI10.1111/1440-1681.12309, lire en ligne, consulté le )
Yi-yang Wang, Hong-mei Li, Hua-dong Wang et Xue-mei Peng, « Pretreatment with Berberine and Yohimbine Protects Against LPS-Induced Myocardial Dysfunction Via Inhibition of Cardiac I-κBα Phosphorylation and Apoptosis in Mice », Shock, vol. 35, no 3, , p. 322–328 (ISSN1073-2322, DOI10.1097/shk.0b013e3181facf73, lire en ligne, consulté le )
Pengfei Liu, Yue Gu, Jie Luo et Peng Ye, « Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1<alpha> signaling pathway », Experimental Cell Research, (ISSN0014-4827, DOI10.1016/j.yexcr.2019.02.022, lire en ligne, consulté le )
Xi Xu, Xiao-Peng Zhu, Jin-Yun Bai et Pu Xia, « Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3 », The FASEB Journal, , fj.201802316R (ISSN0892-6638 et 1530-6860, DOI10.1096/fj.201802316r, lire en ligne, consulté le )
Feifei Zhang, Tong Ma, Peng Cui et Amin Tamadon, « Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine », Frontiers in Microbiology, vol. 10, (ISSN1664-302X, DOI10.3389/fmicb.2019.00175, lire en ligne, consulté le )
(en) Andrés E. Ortiz-Flores, Manuel Luque-Ramírez et Héctor F. Escobar-Morreale, « Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes », Expert Opinion on Pharmacotherapy, vol. 19, no 17, , p. 1915–1926 (ISSN1465-6566 et 1744-7666, DOI10.1080/14656566.2018.1528231, lire en ligne, consulté le )
(en) Meng-Fei Li, Xiao-Meng Zhou et Xue-Lian Li, « The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review », Evidence-Based Complementary and Alternative Medicine, vol. 2018, , p. 1–8 (ISSN1741-427X et 1741-4288, DOI10.1155/2018/2532935, lire en ligne, consulté le )
Sang-Yong Han et Yun-Kyung Kim, « Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression », The American Journal of Chinese Medicine, vol. 47, no 02, , p. 439–455 (ISSN0192-415X et 1793-6853, DOI10.1142/s0192415x19500228, lire en ligne, consulté le )
Lin Lu, Jialang Hu, Qipeng Wu et Ying An, « Berberine prevents human nucleus pulposus cells from IL‑1β‑induced extracellular matrix degradation and apoptosis by inhibiting the NF‑κB pathway », International Journal of Molecular Medicine, (ISSN1107-3756 et 1791-244X, DOI10.3892/ijmm.2019.4105, lire en ligne, consulté le )
Jing Zhou, Yun Yu, Xue Yang et Ying Wang, « Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway », European Journal of Pharmacology, vol. 852, , p. 179–188 (ISSN0014-2999, DOI10.1016/j.ejphar.2019.02.036, lire en ligne, consulté le )
elsevier.com
linkinghub.elsevier.com
(en) Anna Luganini, Beatrice Mercorelli, Lorenzo Messa et Giorgio Palù, « The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity. », Antiviral Research, vol. 164, , p. 52–60 (DOI10.1016/j.antiviral.2019.02.006, lire en ligne, consulté le )
(en) Ting-Chun Hung, Alagie Jassey, Ching-Hsuan Liu et Chien-Ju Lin, « Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein », Phytomedicine, vol. 53, , p. 62–69 (DOI10.1016/j.phymed.2018.09.025, lire en ligne, consulté le )
(en) Matteo Pirro, Daniela Francisci, Vanessa Bianconi et Elisabetta Schiaroli, « NUtraceutical TReatment for hypercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial », Atherosclerosis, vol. 280, , p. 51–57 (DOI10.1016/j.atherosclerosis.2018.11.026, lire en ligne, consulté le )
frontiersin.org
Feifei Zhang, Tong Ma, Peng Cui et Amin Tamadon, « Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine », Frontiers in Microbiology, vol. 10, (ISSN1664-302X, DOI10.3389/fmicb.2019.00175, lire en ligne, consulté le )
harvard.edu
ui.adsabs.harvard.edu
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K, « Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor », Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no 4, , p. 1433–7 (PMID10677479, PMCID26451, DOI10.1073/pnas.030540597, Bibcode2000PNAS...97.1433S)
hindawi.com
(en) Meng-Fei Li, Xiao-Meng Zhou et Xue-Lian Li, « The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review », Evidence-Based Complementary and Alternative Medicine, vol. 2018, , p. 1–8 (ISSN1741-427X et 1741-4288, DOI10.1155/2018/2532935, lire en ligne, consulté le )
issn.org
portal.issn.org
Shiyue Liu, Yi Zhang, Ping Zeng et Heli Wang, « Isolation and Characterization of a Bacterial Strain Capable of Efficient Berberine Degradation », International Journal of Environmental Research and Public Health, vol. 16, no 4, , p. 646 (ISSN1660-4601, DOI10.3390/ijerph16040646, lire en ligne, consulté le )
Rui Zhang, Jie Yang, Juan Wu et Lingling Xiao, « Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration », European Journal of Pharmacology, vol. 851, , p. 144–150 (ISSN0014-2999, DOI10.1016/j.ejphar.2019.02.026, lire en ligne, consulté le )
(en) Chen Xiao, Yan Liu, Qiang Wei et Quan Ji, « Inhibitory Effects of Berberine Hydrochloride on Trichophyton mentagrophytes and the Underlying Mechanisms », Molecules, vol. 24, no 4, , p. 742 (ISSN1420-3049, DOI10.3390/molecules24040742, lire en ligne, consulté le )
(en) Mariana Batista, Ana Braga, Guilherme Campos et Marcos Souza, « Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus », Viruses, vol. 11, no 1, , p. 49 (ISSN1999-4915, DOI10.3390/v11010049, lire en ligne, consulté le )
Shi-Fen Dong, Ying Hong, Ming Liu et Ying-Zhi Hao, « Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats », European Journal of Pharmacology, vol. 660, nos 2-3, , p. 368–374 (ISSN0014-2999, DOI10.1016/j.ejphar.2011.03.024, lire en ligne, consulté le )
Younggeon Jin et Anthony T. Blikslager, « Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury », American Journal of Physiology-Cell Physiology, vol. 311, no 6, , C996–C1004 (ISSN0363-6143 et 1522-1563, DOI10.1152/ajpcell.00113.2016, lire en ligne, consulté le )
Zhouqing Huang, Zhihua Han, Bozhi Ye et Zhenyu Dai, « Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes », European Journal of Pharmacology, vol. 762, , p. 1–10 (ISSN0014-2999, DOI10.1016/j.ejphar.2015.05.028, lire en ligne, consulté le )
Rongxin Zhang, Yuan Yuan Zhang, Xiao R. Huang et Yin Wu, « C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II–Induced Hypertensive Cardiac Disease », Hypertension, vol. 55, no 4, , p. 953–960 (ISSN0194-911X et 1524-4563, DOI10.1161/hypertensionaha.109.140608, lire en ligne, consulté le )
Yuxuan Qiu, Yuanyuan Xie, Kuijing Wang et Gengfeng Liu, « Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways », Experimental and Therapeutic Medicine, vol. 17, no 1, , p. 230–236 (ISSN1792-0981, PMCIDPMC6307361, DOI10.3892/etm.2018.6949, lire en ligne, consulté le )
Hao Chen, Ruo-Qing Zhang, Xiao-Gang Wei et Xiao-Min Ren, « Mechanism of TLR-4/NF-κB pathway in myocardial ischemia reperfusion injury of mouse », Asian Pacific Journal of Tropical Medicine, vol. 9, no 5, , p. 503–507 (ISSN1995-7645, DOI10.1016/j.apjtm.2016.03.021, lire en ligne, consulté le )
Yao-Jun Zhang, Shao-Hua Yang, Ming-Hui Li et Javaid Iqbal, « Berberine attenuates adverse left ventricular remodeling and cardiac dysfunction after acute myocardial infarction in rats: Role of autophagy », Clinical and Experimental Pharmacology and Physiology, vol. 41, no 12, , p. 995–1002 (ISSN0305-1870, DOI10.1111/1440-1681.12309, lire en ligne, consulté le )
Yi-yang Wang, Hong-mei Li, Hua-dong Wang et Xue-mei Peng, « Pretreatment with Berberine and Yohimbine Protects Against LPS-Induced Myocardial Dysfunction Via Inhibition of Cardiac I-κBα Phosphorylation and Apoptosis in Mice », Shock, vol. 35, no 3, , p. 322–328 (ISSN1073-2322, DOI10.1097/shk.0b013e3181facf73, lire en ligne, consulté le )
Pengfei Liu, Yue Gu, Jie Luo et Peng Ye, « Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1<alpha> signaling pathway », Experimental Cell Research, (ISSN0014-4827, DOI10.1016/j.yexcr.2019.02.022, lire en ligne, consulté le )
Xi Xu, Xiao-Peng Zhu, Jin-Yun Bai et Pu Xia, « Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3 », The FASEB Journal, , fj.201802316R (ISSN0892-6638 et 1530-6860, DOI10.1096/fj.201802316r, lire en ligne, consulté le )
Feifei Zhang, Tong Ma, Peng Cui et Amin Tamadon, « Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine », Frontiers in Microbiology, vol. 10, (ISSN1664-302X, DOI10.3389/fmicb.2019.00175, lire en ligne, consulté le )
(en) Andrés E. Ortiz-Flores, Manuel Luque-Ramírez et Héctor F. Escobar-Morreale, « Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes », Expert Opinion on Pharmacotherapy, vol. 19, no 17, , p. 1915–1926 (ISSN1465-6566 et 1744-7666, DOI10.1080/14656566.2018.1528231, lire en ligne, consulté le )
(en) Meng-Fei Li, Xiao-Meng Zhou et Xue-Lian Li, « The Effect of Berberine on Polycystic Ovary Syndrome Patients with Insulin Resistance (PCOS-IR): A Meta-Analysis and Systematic Review », Evidence-Based Complementary and Alternative Medicine, vol. 2018, , p. 1–8 (ISSN1741-427X et 1741-4288, DOI10.1155/2018/2532935, lire en ligne, consulté le )
Sang-Yong Han et Yun-Kyung Kim, « Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression », The American Journal of Chinese Medicine, vol. 47, no 02, , p. 439–455 (ISSN0192-415X et 1793-6853, DOI10.1142/s0192415x19500228, lire en ligne, consulté le )
Lin Lu, Jialang Hu, Qipeng Wu et Ying An, « Berberine prevents human nucleus pulposus cells from IL‑1β‑induced extracellular matrix degradation and apoptosis by inhibiting the NF‑κB pathway », International Journal of Molecular Medicine, (ISSN1107-3756 et 1791-244X, DOI10.3892/ijmm.2019.4105, lire en ligne, consulté le )
Jing Zhou, Yun Yu, Xue Yang et Ying Wang, « Berberine attenuates arthritis in adjuvant-induced arthritic rats associated with regulating polarization of macrophages through AMPK/NF-кB pathway », European Journal of Pharmacology, vol. 852, , p. 179–188 (ISSN0014-2999, DOI10.1016/j.ejphar.2019.02.036, lire en ligne, consulté le )
mdpi.com
(en) Chen Xiao, Yan Liu, Qiang Wei et Quan Ji, « Inhibitory Effects of Berberine Hydrochloride on Trichophyton mentagrophytes and the Underlying Mechanisms », Molecules, vol. 24, no 4, , p. 742 (ISSN1420-3049, DOI10.3390/molecules24040742, lire en ligne, consulté le )
(en) Mariana Batista, Ana Braga, Guilherme Campos et Marcos Souza, « Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus », Viruses, vol. 11, no 1, , p. 49 (ISSN1999-4915, DOI10.3390/v11010049, lire en ligne, consulté le )
Huang WW, Xu SZ, Xu YQ. A study of the antiarrhythmic mechanism of berberine on delayed activation potassium current by voltage clamp. Zhonghua Xin Xue Guan Bing Za Zhi, 20 (5): 310–2, 1992 | PMID1306830
Dong H, Wang N, Zhao L, Lu F, « Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis », Evid Based Complement Alternat Med, vol. 2012, , p. 591654 (PMID23118793, PMCID3478874, DOI10.1155/2012/591654)
Dong H, Zhao Y, Zhao L, Lu F, « The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials », Planta Med., vol. 79, no 6, , p. 437–46 (PMID23512497, DOI10.1055/s-0032-1328321)
Zhao H, Halicka HD, Li J, Darzynkiewicz Z. Berberine suppresses gero-conversion from cell cycle arrest to senescence. Aging (Albany) 2013; 6: 623–636. PMID23974852, DOI10.18632/aging.100593
Darzynkiewicz Z, Zhao H, Halicka HD, Li J, Lee Y-S, Hsieh T-C, Wu J. In search of anti-aging modalities: evaluation of mTOR- and ROS/DNA damage- signaling by cytometry. Cytometry A 2014;85A:386-99. PMID24677687, DOI10.1002/cyto.a.22452
Liu CS, Zheng YR, Zhang YF, Long XY, « Research progress on berberine with a special focus on its oral bioavailability », Fitoterapia, vol. 109, , p. 274–82 (PMID26851175, DOI10.1016/j.fitote.2016.02.001)
Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YO, « Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus », Journal of Medicinal Food, vol. 8, no 4, , p. 454–61 (PMID16379555, DOI10.1089/jmf.2005.8.454)
Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K, « Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor », Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no 4, , p. 1433–7 (PMID10677479, PMCID26451, DOI10.1073/pnas.030540597, Bibcode2000PNAS...97.1433S)
Zhang S, Zhang B, Xing K, Zhang X, Tian X, Dai W, « Inhibitory effects of golden thread (Coptis chinensis) and berberine on Microcystis aeruginosa », Water Science & Technology, vol. 61, no 3, , p. 763–9 (PMID20150713, DOI10.2166/wst.2010.857)
Yuxuan Qiu, Yuanyuan Xie, Kuijing Wang et Gengfeng Liu, « Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways », Experimental and Therapeutic Medicine, vol. 17, no 1, , p. 230–236 (ISSN1792-0981, PMCIDPMC6307361, DOI10.3892/etm.2018.6949, lire en ligne, consulté le )
Yuxuan Qiu, Yuanyuan Xie, Kuijing Wang et Gengfeng Liu, « Berberine protects myocardial cells against anoxia‑reoxygenation injury via p38 MAPK‑mediated NF‑κB signaling pathways », Experimental and Therapeutic Medicine, vol. 17, no 1, , p. 230–236 (ISSN1792-0981, PMCIDPMC6307361, DOI10.3892/etm.2018.6949, lire en ligne, consulté le )
tandfonline.com
(en) Andrés E. Ortiz-Flores, Manuel Luque-Ramírez et Héctor F. Escobar-Morreale, « Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes », Expert Opinion on Pharmacotherapy, vol. 19, no 17, , p. 1915–1926 (ISSN1465-6566 et 1744-7666, DOI10.1080/14656566.2018.1528231, lire en ligne, consulté le )
A.Mat et G. Sariyar, « Alkaloids and Bioactivity of Papaver Dubium Subsp. Dubium and P. Dubium Subsp. Laevigatum », Natural Product Letters, (lire en ligne)